Woe­ful Ax­o­vant starts ax­ing staff, but de­part­ing CEO David Hung gets a $2.6M ex­it pack­age/bonus

When the high-pro­file biotech ex­ec David Hung signed on to helm Ax­o­vant $AX­ON back on April 10, the stock was still rid­ing high at …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA